<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/E30B7145-0051-47F4-B2D6-C93EE14B8568"><gtr:id>E30B7145-0051-47F4-B2D6-C93EE14B8568</gtr:id><gtr:name>University of Oslo</gtr:name><gtr:address><gtr:line1>Boks 1072 Blindern</gtr:line1><gtr:line4>Oslo</gtr:line4><gtr:line5>NO 0316</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Norway</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3ABED15C-DD99-471C-B999-FCE57BF8747B"><gtr:id>3ABED15C-DD99-471C-B999-FCE57BF8747B</gtr:id><gtr:name>UCL Division of Medicine</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/347F2BAC-CB9A-47D4-A649-F5F03F812BAA"><gtr:id>347F2BAC-CB9A-47D4-A649-F5F03F812BAA</gtr:id><gtr:name>NYU Langone Medical Center</gtr:name><gtr:address><gtr:line1>550 First Avenue</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/694EC1A2-4186-4683-9168-67B9E961B56F"><gtr:id>694EC1A2-4186-4683-9168-67B9E961B56F</gtr:id><gtr:name>National Heart &amp; Lung Institute (NHLI)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/96C5D993-E6CA-4E1C-9B98-BB8CEC9A4BFC"><gtr:id>96C5D993-E6CA-4E1C-9B98-BB8CEC9A4BFC</gtr:id><gtr:name>Pasteur Institute, Lille</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/FA571F54-6F0E-48EA-87B8-B07A83E6004B"><gtr:id>FA571F54-6F0E-48EA-87B8-B07A83E6004B</gtr:id><gtr:name>Tsinghua University</gtr:name><gtr:address><gtr:line1>Tsinghua</gtr:line1><gtr:line4>Hai Dian District</gtr:line4><gtr:line5>Beijing</gtr:line5><gtr:postCode>100084</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>China</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DD21B8FC-26A6-4A3A-9A23-207B6667CB41"><gtr:id>DD21B8FC-26A6-4A3A-9A23-207B6667CB41</gtr:id><gtr:name>University of Pittsburgh</gtr:name><gtr:address><gtr:line1>University of Pittsburgh</gtr:line1><gtr:line4>Pittsburgh</gtr:line4><gtr:line5>Pennsylvania</gtr:line5><gtr:postCode>PA 15260</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/0C422A2E-BE95-4551-BD39-D97589C0B7C6"><gtr:id>0C422A2E-BE95-4551-BD39-D97589C0B7C6</gtr:id><gtr:name>Autonomous University of Barcelona (UAB)</gtr:name><gtr:address><gtr:line1>Edifici CN - Campus 08193 Bellatterra</gtr:line1><gtr:line4>Barcelona</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/7BF7535A-C8B7-4782-99FF-1191EBA122A0"><gtr:id>7BF7535A-C8B7-4782-99FF-1191EBA122A0</gtr:id><gtr:name>Spanish Ministry of Economy and Competitiveness</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/468F2797-5295-4912-BDED-8F3402CE246A"><gtr:id>468F2797-5295-4912-BDED-8F3402CE246A</gtr:id><gtr:name>New York University</gtr:name><gtr:address><gtr:line1>7 East 12th Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/091A7281-194A-4C7B-8E9A-0CEB4FEE954B"><gtr:id>091A7281-194A-4C7B-8E9A-0CEB4FEE954B</gtr:id><gtr:name>Faculty of Medicine</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Medicine</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E30B7145-0051-47F4-B2D6-C93EE14B8568"><gtr:id>E30B7145-0051-47F4-B2D6-C93EE14B8568</gtr:id><gtr:name>University of Oslo</gtr:name><gtr:address><gtr:line1>Boks 1072 Blindern</gtr:line1><gtr:line4>Oslo</gtr:line4><gtr:line5>NO 0316</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Norway</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3ABED15C-DD99-471C-B999-FCE57BF8747B"><gtr:id>3ABED15C-DD99-471C-B999-FCE57BF8747B</gtr:id><gtr:name>UCL Division of Medicine</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/347F2BAC-CB9A-47D4-A649-F5F03F812BAA"><gtr:id>347F2BAC-CB9A-47D4-A649-F5F03F812BAA</gtr:id><gtr:name>NYU Langone Medical Center</gtr:name><gtr:address><gtr:line1>550 First Avenue</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/694EC1A2-4186-4683-9168-67B9E961B56F"><gtr:id>694EC1A2-4186-4683-9168-67B9E961B56F</gtr:id><gtr:name>National Heart &amp; Lung Institute (NHLI)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/96C5D993-E6CA-4E1C-9B98-BB8CEC9A4BFC"><gtr:id>96C5D993-E6CA-4E1C-9B98-BB8CEC9A4BFC</gtr:id><gtr:name>Pasteur Institute, Lille</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/FA571F54-6F0E-48EA-87B8-B07A83E6004B"><gtr:id>FA571F54-6F0E-48EA-87B8-B07A83E6004B</gtr:id><gtr:name>Tsinghua University</gtr:name><gtr:address><gtr:line1>Tsinghua</gtr:line1><gtr:line4>Hai Dian District</gtr:line4><gtr:line5>Beijing</gtr:line5><gtr:postCode>100084</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>China</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DD21B8FC-26A6-4A3A-9A23-207B6667CB41"><gtr:id>DD21B8FC-26A6-4A3A-9A23-207B6667CB41</gtr:id><gtr:name>University of Pittsburgh</gtr:name><gtr:address><gtr:line1>University of Pittsburgh</gtr:line1><gtr:line4>Pittsburgh</gtr:line4><gtr:line5>Pennsylvania</gtr:line5><gtr:postCode>PA 15260</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/0C422A2E-BE95-4551-BD39-D97589C0B7C6"><gtr:id>0C422A2E-BE95-4551-BD39-D97589C0B7C6</gtr:id><gtr:name>Autonomous University of Barcelona (UAB)</gtr:name><gtr:address><gtr:line1>Edifici CN - Campus 08193 Bellatterra</gtr:line1><gtr:line4>Barcelona</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/7BF7535A-C8B7-4782-99FF-1191EBA122A0"><gtr:id>7BF7535A-C8B7-4782-99FF-1191EBA122A0</gtr:id><gtr:name>Spanish Ministry of Economy and Competitiveness</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/468F2797-5295-4912-BDED-8F3402CE246A"><gtr:id>468F2797-5295-4912-BDED-8F3402CE246A</gtr:id><gtr:name>New York University</gtr:name><gtr:address><gtr:line1>7 East 12th Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/091A7281-194A-4C7B-8E9A-0CEB4FEE954B"><gtr:id>091A7281-194A-4C7B-8E9A-0CEB4FEE954B</gtr:id><gtr:name>Faculty of Medicine</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/F4105BE4-4921-4BD6-A0DF-1A04D37DBD67"><gtr:id>F4105BE4-4921-4BD6-A0DF-1A04D37DBD67</gtr:id><gtr:firstName>Ines</gtr:firstName><gtr:surname>Pineda Torra</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0801278"><gtr:id>E1696D8B-DB8D-4F3C-8770-F05B160E0F68</gtr:id><gtr:title>Role of LXR alpha phosphorylation in macrophage activation and atherogenesis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801278</gtr:grantReference><gtr:abstractText>Atherosclerosis is a disease caused by the build up of fatty material (cholesterol) in blood vessels (arteries) causing them to narrow, which reduces the amount of blood and oxygen delivered to vital organs. Both cholesterol and inflammation play an important role in the initiation and progression of the disease. Activation of the receptor LXRa_decreases atherosclerosis in animal models and its ligands could potentially treat the disease in humans. Macrophages are specialized cells that eat and digest germs, are present in the arteries and are crucial for the progression of the disease. There are two types of macrophages, ?classically? activated and pro-inflammatory and the ?alternatively? activated and anti-inflammatory. Activation of LXRa by specific compounds (ligands) increases the production of certain genes. We have found that one of those genes, called arginase I, is characteristic of the alternative activation state of macrophages. In addition, we have seen that by introducing a specific mutation in the receptor we can also activate it resulting in even more elevated levels of arginase I. We hypothesize that activation of LXRa may also affect the production of other genes so that its activation induces is a switch from the classical to the alternative state of macrophages. This would change the inflammatory status of these cells and could ultimately affect the progression of atherosclerosis. We also believe that the specific mutation in LXRa would influence this activation switch. We have cell lines that express the unmodified LXRa receptor, and cells that express the mutated LXRa. Using these cells we aim to first determine what is the mechanism that explains the induction of arginase 1 in cells that have the mutated receptor. Next we will determine whether the cells with the mutated receptor are in a more alternative state and therefore if they are less inflammatory compared with cells having the unmodified receptor. Finally, to examine that effects in these cells can affect the whole body and the development of atherosclerosis we propose to generate a mouse model that will have the mutated receptor. Then we will investigate if the mutation has an effect on inflammation in these mice and whether it affects the progression of the atherosclerosis compared to mice that have the unmodified receptor in their cells. The proposed work will provide a deeper understanding on how we can regulate the LXRa receptor and could eventually lead to novel therapies for the treatment of atherosclerosis and other inflammatory diseases.</gtr:abstractText><gtr:technicalSummary>LXRs (a and b) are ligand-activated transcription factors that behave like cholesterol content sensors. Activation of LXRs inhibit the development of atherosclerosis and macrophage LXR activity is required for this inhibition. LXRa activation also reduces inflammation and decreases progression of atherosclerosis and insulin resistance. Therefore LXRs are now considered promising drug development targets for the management of metabolic and inflammatory diseases. Th1 cytokines induce a classical activation state while Th2 cytokines such as IL-4 induce an anti-inflammatory alternative activation program in macrophages. Interestingly, induction of Th2-cell responses affects the development of atherosclerosis. LXR activation inhibits classical macrophage activation. However, the impact of LXRa on the alternative activation status of macrophages and its physiological implications remains unexplored. We previously demonstrated that modulation of LXRa phosphorylation regulates LXRa actions. Our preliminary studies now show that LXRa activation in the macrophage RAW 264.7 cell line induces the expression and IL-4 induction of markers for the alternative (anti-inflammatory) activation, such as arginase I (ArgI). Reduction of LXRa phosphorylation markedly enhances these effects. Thus we hypothesize that changes in LXRa expression and phosphorylation may play a role in macrophage polarization towards the alternative anti-inflammatory state. In turn, this would affect macrophage inflammation and may have important physiological consequences in the development of atherosclerosis. In this proposal we will first aim to elucidate the mechanisms underlying the regulation of ArgI by LXRa. We will characterize ArgI promoter activity, mRNA and protein expression as well as enzymatic activity upon changes in LXRa expression and phosphorylation. RAW-LXRa WT and S198A stable cell lines as well as primary macrophages will be employed. Next, the impact of LXRa expression and phosphorylation on macrophage activation status and inflammation will be investigated by measuring pro- and anti-inflammatory cytokines and markers for each state. Finally, the physiological relevance of LXRa phosphorylation will be investigated by generating mice homozygous for the phosphorylation site mutation. The influence of LXRa phosphorylation on the activation state of resident macrophages from these mice will be examined. Additionally, the impact of LXRa phosphorylation on atherogenesis will be also investigated by crossing these mutant mice with the apoE-deficient mouse atherosclerosis model. Intracellular lipid and macrophage content analysis of the lesions will be performed and the expression of macrophage inflammatory markers within the plaque will be examined. Successful completion of the present proposal will provide a better understanding of the pathophysiological consequences of LXRa transcriptional actions in response to its phosphorylation.</gtr:technicalSummary><gtr:fund><gtr:end>2013-11-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>494807</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Autonomous University of Barcelona (UAB)</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:department>Department of Cellular Biology, Physiology and Immunology</gtr:department><gtr:description>Collaboration with Dr Annabel Valledor-2</gtr:description><gtr:id>B243A7CA-6170-48F4-886A-81D395EAACB6</gtr:id><gtr:impact>This collaborator is coauthor in a publication in the journal Scientific Reports. We expect other manuscripts to be submitted in the near future.</gtr:impact><gtr:partnerContribution>She shares her unpublished results on the modulation of interferon regulated pathways. We have used her experiments and technical conditions to test how a particular interferon regulated gene is affected by LXR activity. Additionally, she provides tissue material from LXR-deficient mice to directly investigate the contribution of LXR in the identified targeted pathways.</gtr:partnerContribution><gtr:piContribution>We share our results on the regulation of inflammatory pathways by LXR performed with some of her reagents.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Karolinska Institute</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Collaboration with ET</gtr:description><gtr:id>590F329B-3C87-4781-B3BF-D2568762D0A1</gtr:id><gtr:impact>ET and members of her team are co-athors in a manuscript we are currently preparing describing this studies.</gtr:impact><gtr:partnerContribution>They have provided protocols to analyse transcription factor binding in liver which has helped us explain our data, namely, changes in gene expression we observed in our animal model. They have provided unpublished data to identify where transcription factors and transcriptional correpressor molecules are bound to liver genes in response to specific activators that we have used to conduct further experiments to understand the mechanistic basis of our obseravtions.</gtr:partnerContribution><gtr:piContribution>We shared protocols to use phosphorylation-specific antibodies and more recently have shared unpublished data on gene regulation in our phosphorylation knock in models.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Heart &amp; Lung Institute (NHLI)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Vascular Sciences Section</gtr:department><gtr:description>Collaboration with Dr. Joseph Boyle</gtr:description><gtr:id>8ACFC40C-103B-46ED-948B-7397F8D23358</gtr:id><gtr:impact>No outputs yet.</gtr:impact><gtr:partnerContribution>He gaves us information about reagents and protocols on how to activate the cells in a particular way</gtr:partnerContribution><gtr:piContribution>We will assay whether some of the results obtained by Dr Boyle regarding gene regulation in a particular macrophages subtype are differentially affected in our mice models</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oslo</gtr:collaboratingOrganisation><gtr:country>Norway, Kingdom of</gtr:country><gtr:description>Collaboration with Hanne RL</gtr:description><gtr:id>6995E8E5-EB37-4804-9298-2B9272248FCC</gtr:id><gtr:impact>A first series of analyses were included in applications for funding earlier this year and will also be incorporated in an upcoming application to the Wellcome Trust.
A second set of analyses has been included in a manuscript we have in preparation that will soon be submitted for publication.</gtr:impact><gtr:partnerContribution>She analysed samples.</gtr:partnerContribution><gtr:piContribution>We provided plasma and tissue samples to have analysed as part of our research projects.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>UCL Division of Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Inflammation and Tissue Repair</gtr:department><gtr:description>Collaboration with Prof Rachel Chambers</gtr:description><gtr:id>DBDD4E28-5C00-409F-B21A-C7022F7D1653</gtr:id><gtr:impact>We have a PhD student in common</gtr:impact><gtr:partnerContribution>They are specialists in inflammation and fibrosis and they assist with reagents, protocols, equipment for histology and intellectual support</gtr:partnerContribution><gtr:piContribution>We initially aimed to investigate the regulation of lung inflammation and fibrosis by the nuclear receptor LXRa in our mice models carrying a mutation in the LXRa receptor. We are now focusing our efforts on studies on liver fibrosis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Tsinghua University China</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:department>Institute for Immunology</gtr:department><gtr:description>Collaboration with Dr Xiaoyu Hu</gtr:description><gtr:id>FA574E61-2A35-4EC6-A67B-7413CA3B5C6C</gtr:id><gtr:impact>Publication of a Circulation Research paper describing the regulation of Arginase 1 by IRF8.
Publication of a Scientific reports paper using materials provided by the collaborator.
Awarded a Newton Advanced Fellowship by the Academy of Medical Sciences for which I am the UK co-PI</gtr:impact><gtr:partnerContribution>Her group initially provided cellular material from an IRF8-deficient mice model. They have now shared unpublished data on the role of modulators of IRF8 on intestinal macrophages in models of intestinal inflammation and have provided protocols to perform similar experiments in the UK using our animal models.</gtr:partnerContribution><gtr:piContribution>We have investigated the regulation of macrophage gene expression by IRF8, a transcription factor in which she is an expert. We have also now generated myeloid-specific IRF8-deficient mice that are being used by the collaborator on a project we have been co-awarded by the Academy of Medical Sciences (Newton advanced Fellowship).</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>UCL Division of Medicine</gtr:department><gtr:description>Collaboration with Dr Liz Jury</gtr:description><gtr:id>618F5AB3-08FA-423C-8660-B155831735CC</gtr:id><gtr:impact>Her group has an article in the Journal of Clinical Investigation in which our help is acknowledged.
We shared rotation student that is part of a BHF 4 year studentship program with a project looking at the regulation of LXR target gene expression in human immune cells that now has been extended into a full PhD studentship.
I am secondary supervisor of another PhD student (second year).
An abstract of our shared work was presented in Dublin (May 2014) , at a Keystone meeting on Immunometabolism (February 2016), American College of Rheumatology (November 2016) and British Immunological Society (Dec2016).
I was senior co-author of a recent publication in Science Immunology (Dec 2016) in which she is senior author and our shared PhD student is first co-shared author.
We have submitted a project research grant to the BBSRC with the data obtained by this PhD student, an application for the Multiple Sclerosis Society project grant (Feb 2017) and Co-PI in an Arthritis Research UK outline application (Feb 2017). We are now putting together an application for a Collaborative Award by the Wellcome Trust (outline submission in April 2017)</gtr:impact><gtr:partnerContribution>She is an expert in Lymphocyte biology in Lupus and other autoimmune diseases. She provides cellular material to investigate the role of LXR in autoimmune diseases and intellectual support for this and other projects.</gtr:partnerContribution><gtr:piContribution>We provide expertise, reagents, protocols and intellectual support regarding the nuclear receptor LXR and the regulation of lipid metabolism in cardiometabolic diseases.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Medicine Pittsburgh</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Microbiology and Molecular Genetics</gtr:department><gtr:description>Collaboration with Prof. Sidney Morris</gtr:description><gtr:id>EE6F8993-D125-47F9-B6FF-1C1928119B61</gtr:id><gtr:impact>This collaboration has resulted in research presented in poster and oral format in one national and 5 international meetings and a publication in Circulation Research.</gtr:impact><gtr:partnerContribution>This collaborator has provided unique reagents (plasmids and antibodies) as well as expert insight into a particular pathway which have been crucial for carrying out the research described in the proposal.</gtr:partnerContribution><gtr:piContribution>We have provided protocols, give insight to transcriptional mechanisms mediated by LXR and made our results available to them before publication.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>UCL Division of Medicine</gtr:department><gtr:description>Collaboration with Dr Krista Rombouts</gtr:description><gtr:id>9F3BAFE0-F7B3-4BF5-9E06-6BF70492475A</gtr:id><gtr:impact>Data obtained has been incorporated in a manuscript we are preparing and several applications to obtain additional external funding</gtr:impact><gtr:partnerContribution>Share cell and tissue samples</gtr:partnerContribution><gtr:piContribution>Share unpublished data, analysis of gene and protein expression on samples provided by the collaborator</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Spanish Ministry of Economy and Competitiveness</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:department>Spanish National Research Council (CSIC)</gtr:department><gtr:description>Collaboration with Dr. Antonio Castrillo</gtr:description><gtr:id>983E534F-61A4-418B-8CFF-3676ED1EF4C3</gtr:id><gtr:impact>Coauthor in publication in the journal Scientific Reports. He is named collaborator in grant applications to the BBSRC and will be a PI in the team of collaborators gathered for a Wellcome Trust Collaborative Award application.</gtr:impact><gtr:partnerContribution>They provided samples from mice that are deficient in the receptor of our interest and intellectual input for the design and generation of novel antibodies. They are now designing new antibodies using LXR expression plasmids that we provided. They share unpublished data on binding sites for transcription factors in reposes to their respective ligands in macrophages.</gtr:partnerContribution><gtr:piContribution>We initially provided protocols and antibodies for the chromatin immunoprecipitation assay from macrophage cells, also intellectual input and reagents for the design and generation of novel antibodies. We have now generated myeloid-specific IRF8 knockouts. We are using macrophages from these mice to explore the role of IRF8 on the regulation of LXR target genes identified by this collaborator.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>NYU Langone Medical Center</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Division of Cardiology</gtr:department><gtr:description>Collaboration with Prof. Edward Fisher</gtr:description><gtr:id>67528BA2-9C78-40C3-B620-3ED4E9197D89</gtr:id><gtr:impact>This collaboration has resulted in research presented in poster and oral format in national and international meetings and a publication in Circulation Research. Additional publications are to be expected from this collaboration.</gtr:impact><gtr:partnerContribution>This collaborator contributed to one study by sharing with us experiments performed in his group and making data available to us to be used for publication. His group will now perform an additional set of experiments that will help characterise our animal models to finalise a study for publication. This collaborator is also providing important protocols for the completions of our studies.</gtr:partnerContribution><gtr:piContribution>We provide insight on LXR regulated pathways and share unpublished data on our animal models. We have now also shared some of our animal models to develop complimentary studies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Lille</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Collaboration with Prof Bart Staels</gtr:description><gtr:id>B03C3BD6-5089-4EB2-A8F2-E09D3CB53F52</gtr:id><gtr:impact>For the past two years I have been the external examiner of one of his PhD students (yearly evaluations before PhD Viva that are compulsory in France).</gtr:impact><gtr:partnerContribution>They share unpublished data and expertise on disease experimental models</gtr:partnerContribution><gtr:piContribution>We share unpublished data from our experimental models of atherosclerosis and inflammation disease</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>New York University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>NYU Langone Medical Center</gtr:department><gtr:description>Collaboration with Prof Garabedian</gtr:description><gtr:id>4097B335-131A-45E7-A29A-505C5DF027D1</gtr:id><gtr:impact>This collaborator was a coauthor in a Circulation Research publication (2011). We were senior authors in a Molecular Cell Biology Publication in 2015. He and a member of his team are co-authors in a manuscript that will soon be submitted for publication. Other shared publications are expected in the coming years.</gtr:impact><gtr:partnerContribution>They share unpublished data, protocols and methodology and unique antibody reagents. They have sharer liver samples from one of their experimental protocols that will be analysed by us. They will stain tissue sections from our animal models to investigate the expression of one of our proteins of interest.</gtr:partnerContribution><gtr:piContribution>We provided novel experimental models with a mutation in the receptor of our interest. We share unpublished data, protocols and methodology. We will next analyse gene and protein expression in liver samples from one of their experiments.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Faculty of Medicine</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:department>Department of Cell Biology, Immunology and Neuroscience</gtr:department><gtr:description>Collaboration with Dr Annabel Fernandez Valledor</gtr:description><gtr:id>60FE2EB5-0669-4368-A8E8-2B24E0592327</gtr:id><gtr:impact>They are co-authors in a manuscript that is being prepared for submission in the upcoming weeks.</gtr:impact><gtr:partnerContribution>They provide macrophages from LXRa deficient mice to test that the expression of the genes identified is dependent on LXR</gtr:partnerContribution><gtr:piContribution>We provide information on genes differentially regulated by an LXRa phospho-deficient mutant receptor in macrophages</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London (QMUL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>William Harvey Research Institute</gtr:department><gtr:description>Collaboration with Professor Adrian Hobbs</gtr:description><gtr:id>A7FD9B6B-A912-48C4-8CD2-B9048656634A</gtr:id><gtr:impact>This collaboration was important for one of our studies and its publication in a peer-reviewed journal last summer.
This collaborator was a co-applicant in a funding proposal to the BHF that was unsuccessful.</gtr:impact><gtr:partnerContribution>This collaborator previously contributed with data to a study published in Circulation Research.
He is providing animal models in which to check the regulation of inflammatory pathways by LXR</gtr:partnerContribution><gtr:piContribution>We are investigating the effects of a specific set of ligands on lung inflammatory pathways in different animal models</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>UCL Mechanical Engineering</gtr:department><gtr:description>Collaboration with VD</gtr:description><gtr:id>64AD12E8-6E4F-4BAC-BC6C-4A9648F40CA9</gtr:id><gtr:impact>Vanessa and and her team member are co-authors in a manuscript currently in preparation. This is part of a multi-disciplinary collaboration involving engineering, biology and imaging.</gtr:impact><gtr:partnerContribution>Her team developed a new software to analyse the accumulation of lipids in tissue.</gtr:partnerContribution><gtr:piContribution>We provided samples from atherosclerotic and metabolic disease mouse models.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visit (Henrietta Barnett School-London)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>3D6FEBAC-1412-4913-8FCC-6E2F7F7CCB40</gtr:id><gtr:impact>20 B12 students and their Science teacher attended a 30 min presentation plus a Q&amp;amp;A of 15 mins. A student approached me at the end and is interested in shadowing researchers in my group.

There will be a shadowing type of visit for two students of one week each next year during the school holidays. In this visit the students will be able to experience first hand what is like to do research in a lab and attend lab meetings and scientific seminars in our department.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.ucl.ac.uk/prospective-students/widening-participation/teachers/STEM-women-speakers</gtr:url><gtr:year>2013,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit to Science Cafe at QK Academy</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>70C91E85-451D-4CE6-86C2-ED37BB9133B0</gtr:id><gtr:impact>Discussion about non-medical studies with biomedical relevance, admission to a university such as UCL, possibilities in biomedical research. Two students (one undergraduate and one PhD student) came with me to share their work with students. This sparked a lot of discussion and some students expressed their interest to come shadow researchers in my group. This is the feedback I got from the organiser:
&amp;quot;We have had a few of these Science cafes already but this was by far the most engaging and relevant to the students.
I would also like to say a huge thank you to the students that you brought with you. It was very important for the students to speak to students who have and are currently going through the university system.&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.ucl.ac.uk/prospective-students/widening-participation/teachers/STEM-women-speakers</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit to Heston Community School</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>973D3462-1FBE-41DF-9373-67555F2DC5C5</gtr:id><gtr:impact>Discussion about non-medical studies with biomedical relevance, admission to a university such as UCL, possibilities in biomedical research. The event was reported in the school newsletter. Students also helped with their opinions of what scientists look like for a TEDex talk at UCL on gender stereotypes for scientists (May 2015).</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.ucl.ac.uk/prospective-students/widening-participation/teachers/STEM-women-speakers</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit to St Georges Catholic school</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>92A5D148-AF88-436C-A6F3-B3D7901B3164</gtr:id><gtr:impact>Discussion about non-medical studies with biomedical relevance, admission to a university such as UCL, possibilities in biomedical research

Not known</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.ucl.ac.uk/prospective-students/widening-participation/teachers/STEM-women-speakers</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit to Lansdowne College</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>7A4E4D96-FC7A-44B4-B020-F4125E771C95</gtr:id><gtr:impact>Discussion about non-medical studies with biomedical relevance, admission to a university such as UCL, possibilities in biomedical research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.ucl.ac.uk/prospective-students/widening-participation/teachers/STEM-women-speakers</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit to Chelsea Independent College</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>729AA86E-B0DF-4044-9755-6EDD9081AAC1</gtr:id><gtr:impact>Discussion about non-medical studies with biomedical relevance, admission to a university such as UCL, possibilities in biomedical research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.ucl.ac.uk/prospective-students/widening-participation/teachers/STEM-women-speakers</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit to Clapton Girls Academy</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>C486FEAF-5F05-4659-ABAE-82CCA82C4BCE</gtr:id><gtr:impact>Discussion about non-medical studies with biomedical relevance, admission to a university such as UCL, possibilities in biomedical research.
After the visit two students expressed their interest and visited my lab where they each shadowed a researcher in my group for one day exposing them to the ways we do research in the lab and scientific discussions between members of the lab. Both students were very grateful and deeply enjoyed the opportunity. Students also helped with their opinions of what scientists look like for a TEDex talk at UCL on gender stereotypes for scientists (May 2015).</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.ucl.ac.uk/prospective-students/widening-participation/teachers/STEM-women-speakers</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit to Isabel the Catholic School (Madrid, Spain)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6D490A0E-6A1B-4ADA-9FE6-4541A5F4E3F7</gtr:id><gtr:impact>Discussion about careers in science, non-medical studies with biomedical relevance, University studies, possibilities in biomedical research. Aprox 250 pupils from 14-16 yrs old attended and presentations were followed by an animated debate with the students.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>69000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Grand Challenges PhD Studentship</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>University College London (UCL)</gtr:fundingOrg><gtr:id>05034B6B-1E22-4AB6-BFAB-EE9632C7AA57</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>4month BHF Rotation Studentship</gtr:description><gtr:end>2014-01-02</gtr:end><gtr:fundingOrg>University College London (UCL)</gtr:fundingOrg><gtr:id>164F507A-AEC4-4764-8ADF-A25F3CE58D09</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>271700</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Project Grant</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>PG/13/10/30000</gtr:fundingRef><gtr:id>CFD40815-A11B-41E3-AFB3-264A640EE794</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Mouse liver transcriptome on diet-caparison between wild type and mutated mice: GEO Submission (GSE95359)</gtr:description><gtr:id>55A401BD-059F-4FC5-935F-3DFA04C57E4D</gtr:id><gtr:impact>Data included in manuscript in preparation.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Gene expression analysis-liver HFHC</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Mouse liver transcriptome on chow diet comparing wild type and mutated transcription factor- GSE96650</gtr:description><gtr:id>7A9E19F7-56AA-4A38-B91F-1E6AA8F63975</gtr:id><gtr:impact>Data and analysis are included in manuscript in preparation.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Gene expression analysis liver chow diet</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Plasmids encoding the PU.1 transcription factor cDNA in which published and potential phosphorylation sites have been mutated</gtr:description><gtr:id>596029EC-F9D9-49E2-AEF9-89D113B0A6DC</gtr:id><gtr:impact>This plasmids have helped us characterize the regulation of PU.1 target gene expression and the relevance of PU.1 phosphorylation in these processes.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Mutated PU.1 transcription factor cDNA plasmids</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Modified mouse line in which a mutation in the phosphorylation site of the LXRa gene has been knocked in in all tissues and cells</gtr:description><gtr:id>AACD2A27-46B7-427E-B4B1-D43F722F710C</gtr:id><gtr:impact>Two different labs, mine and a collaborator in the US, are characterising the metabolic disturbances and effects on the development of cardiovascular diseases</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Global LXRaS196 mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Modified mouse line in which a mutation in the phosphorylation site of the LXRa gene has been knocked in in monocytes/macrophages and neutrophils</gtr:description><gtr:id>CD33AB34-EDAE-4BC4-89B8-5221C21C368D</gtr:id><gtr:impact>We are in the process of characterizing these mice</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>LXRaS196A-Mac mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A collection of murine arginase 1 promoter constructs that have been mutated at different transcription factor binding sites</gtr:description><gtr:id>6C5175B3-685A-4CD1-87D9-C948D60CFAFD</gtr:id><gtr:impact>These constructs have helped us characterize the regulation of arginase 1 transcription in macrophages by different transcription factors</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Mutated arginase 1 promoter constructs</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Modified mice line in which a mutation in the phosphorylation site of the LXRa gene will be conditionally knocked in once these mice are bred with tissue/cell type specific Cre recombinase expressing mice</gtr:description><gtr:id>DF1F26A5-C15A-4086-9B75-13E88FE9FCC9</gtr:id><gtr:impact>We have successfully bred this mice with a line of mice expressing Cre recombinase in monocytes/macrophages/neutrophils to generate a novel line of mice with a knocked in mutation in those cells . A collaborator has used this line to generate a novel tamoxifen-inducible line to further explore the effects of phosphorylation of this receptor in an inducible manner.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>LXRaS196A-Flp mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Modified mouse line in which a mutation in the phosphorylation site of the LXRa gene has been knocked in in monocytes/macrophages and neutrophils in the atherosclerotic background (LDL receptor knock out)</gtr:description><gtr:id>8AFE02E7-89A1-4F5B-8BBE-152BF9CDFE76</gtr:id><gtr:impact>With these animals we are now investigating the effect of the phosphorylation of the receptor on the development of atherosclerosis. We are now characterising the atherosclerotic lesions of these mice to obtain preliminary data to obtain further funding.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>MacLXRaS196A-LDLRKO</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>This is doen in collaboration with members of the mechanical engineering department. The software allows a non-biased identification of round white lipid droplets on hematoxylin and Eosin stained liver sections. Software also allows quantification of number of lipid droplets and area and diameter distribution.</gtr:description><gtr:id>7A1EA863-636D-40A5-9BFC-3B9693AFEC51</gtr:id><gtr:impact>This allows non-biased identification and quantification and has been used in two of the ongoing studies in my laboratory that will be submitted for publication in 2016.</gtr:impact><gtr:title>Software for the measurement of liver lipid droplets</gtr:title><gtr:type>Software</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3C5D635E-16BB-4F2F-B9AA-B206F5EFD634"><gtr:id>3C5D635E-16BB-4F2F-B9AA-B206F5EFD634</gtr:id><gtr:title>Post-translational modifications of lipid-activated nuclear receptors: Focus on metabolism.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ae1a5be2a2757687e46b7403870d2b97"><gtr:id>ae1a5be2a2757687e46b7403870d2b97</gtr:id><gtr:otherNames>Becares Salles N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4F1F164D-1DC7-4181-A30E-FF0FC8D6448B"><gtr:id>4F1F164D-1DC7-4181-A30E-FF0FC8D6448B</gtr:id><gtr:title>Luciferase Reporter Assays to Assess Liver X Receptor Transcriptional Activity.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/aee798430ac80ab034fed8a9d79504c9"><gtr:id>aee798430ac80ab034fed8a9d79504c9</gtr:id><gtr:otherNames>Gage MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5A7422A9-B245-4E7F-85A8-A9FF77F8AD2B"><gtr:id>5A7422A9-B245-4E7F-85A8-A9FF77F8AD2B</gtr:id><gtr:title>Isolation, Culture, and Polarization of Murine Bone Marrow-Derived and Peritoneal Macrophages.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c37859665930a3dbabebf02b860a12a0"><gtr:id>c37859665930a3dbabebf02b860a12a0</gtr:id><gtr:otherNames>Pineda-Torra I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:isbn>978-1-4939-2929-0</gtr:isbn><gtr:issn>1064-3745</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/63C51701-1DF6-4C0B-B833-BA196BC0BFD9"><gtr:id>63C51701-1DF6-4C0B-B833-BA196BC0BFD9</gtr:id><gtr:title>Transcriptional regulation of macrophage arginase 1 expression and its role in atherosclerosis.</gtr:title><gtr:parentPublicationTitle>Trends in cardiovascular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/805b32cc228e73eb186bab48cd348597"><gtr:id>805b32cc228e73eb186bab48cd348597</gtr:id><gtr:otherNames>Pourcet B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1050-1738</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A8FB3170-13C3-4B92-A6AA-33A21CE6BCE6"><gtr:id>A8FB3170-13C3-4B92-A6AA-33A21CE6BCE6</gtr:id><gtr:title>Liver X receptors in immune cell function in humans.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7d1d8746ab73aa10a5288c40d4526335"><gtr:id>7d1d8746ab73aa10a5288c40d4526335</gtr:id><gtr:otherNames>Waddington KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AE3D1075-7B31-4539-BB66-436EE79E9789"><gtr:id>AE3D1075-7B31-4539-BB66-436EE79E9789</gtr:id><gtr:title>Modulation of Macrophage Gene Expression via Liver X Receptor a Serine 198 Phosphorylation.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1a86fb804dd161bd520ef0e0c1b13874"><gtr:id>1a86fb804dd161bd520ef0e0c1b13874</gtr:id><gtr:otherNames>Wu C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/187F67EE-8886-4C29-963C-676A223F5F29"><gtr:id>187F67EE-8886-4C29-963C-676A223F5F29</gtr:id><gtr:title>The nuclear receptor LXR modulates interleukin-18 levels in macrophages through multiple mechanisms.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/805b32cc228e73eb186bab48cd348597"><gtr:id>805b32cc228e73eb186bab48cd348597</gtr:id><gtr:otherNames>Pourcet B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/765155FE-E330-40A9-A424-ED1D617C2356"><gtr:id>765155FE-E330-40A9-A424-ED1D617C2356</gtr:id><gtr:title>LXRa regulates macrophage arginase 1 through PU.1 and interferon regulatory factor 8.</gtr:title><gtr:parentPublicationTitle>Circulation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/805b32cc228e73eb186bab48cd348597"><gtr:id>805b32cc228e73eb186bab48cd348597</gtr:id><gtr:otherNames>Pourcet B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0009-7330</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0801278</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>